ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

1-Hydroxybenzotriazole → 5-(2-Fluoro-phenyl)-isoxazole-3-carboxylic acid {2-[4-(2-chloro-phenylamino)-piperidin-1-yl]-2-oxo-ethyl}-amide

HRID 1093755
ノート
印刷プレビュー

反応式

HRID 1093755 の反応式
CCN(C(C)C)C(C)C.[F:10][C:11]1[CH:16]=[CH:15][CH:14]=[CH:13][C:12]=1[C:17]1N[N:20]=[C:19]([C:22]([OH:24])=O)[CH:18]=1.FC1C=CC=CC=1C(=[O:34])C.C1C=CC2N(O)N=NC=2C=1.CCN=C=NCCCN(C)C.Cl.Cl.Cl.[NH2:59][CH2:60][C:61]([N:63]1[CH2:68][CH2:67][CH:66]([NH:69][C:70]2[CH:75]=[CH:74][CH:73]=[CH:72][C:71]=2[Cl:76])[CH2:65][CH2:64]1)=[O:62]>CN(C=O)C.O>[Cl:76][C:71]1[CH:72]=[CH:73][CH:74]=[CH:75][C:70]=1[NH:69][CH:66]1[CH2:67][CH2:68][N:63]([C:61](=[O:62])[CH2:60][NH:59][C:22]([C:19]2[CH:18]=[C:17]([C:12]3[CH:13]=[CH:14][CH:15]=[CH:16][C:11]=3[F:10])[O:34][N:20]=2)=[O:24])[CH2:64][CH2:65]1
参加物実験手順後処理出典と根拠反応ノート

参加物

9

反応物 6

HCID 757711-HydroxybenzotriazoleHCID 81531DiisopropylethylamineHCID 96744o-FluoroacetophenoneHCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 665917512-Amino-1-[4-(2-chloro-phenylamino)-piperidin-1-yl]-ethanone dihydrochlorideHCID 178524114HCID 178524114、化合物

生成物 1

HCID 578744785-(2-Fluoro-phenyl)-isoxazole-3-carboxylic acid {2-[4-(2-chloro-phenylamino)-piperidin-1-yl]-2-oxo-ethyl}-amide収率 26.6%

試薬・触媒・溶媒 2

HCID 962Water溶媒HCID 6228Dimethylformamide溶媒

実験手順

DIPEA (328 mg, 2.5 mmol) to a stirred solution of 5-(2-fluoro-phenyl)-1H-pyrazole-3-carboxylic acid (150 mg, 0.724 mmol) (prepared by the method used for the synthesis of Intermediate 29, starting from 2′fluoroacetophenone) in DMF (5 mL) followed by HOBt (100 mg, 0.76 mmol) and EDCI.HCl (140 mg, 0.76 mmol). After 2 minutes 2-amino-1-[4-(2-chloro-phenylamino)-piperidin-1-yl]-ethanone dihydrochloride (220 mg, 0.724 mmol) was added to the reaction mixture and stirring was continued at ambient temperature overnight. The reaction mixture was diluted with cold water, the precipitate was collected. The solid was purified by recrystallisation from ethyl acetate The residue obtained was again purified by column chromatography (using 60-120 silica gel and 60% EtOAc in hexane as eluent) to afford 88 mg (26.6% Yield) of 5-(2-fluoro-phenyl)-isoxazole-3-carboxylic acid {2-[4-(2-chloro-phenylamino)-piperidin-1-yl]-2-oxo-ethyl}-amide. LC/MS [M+H]+: 457, 91.47%. 1H NMR (300 MHz, DMSO-d6): δ8.75 (t, 1H), 8.0 (m, 1H), 7.6 (m, 1H), 7.38 (m, 2H), 7.1 (m, 3H), 6.82 (d, 1H), 6.6 (m, 1H), 4.8 (m, 1H), 4.3 (d, 1H), 4.1 (d, 2H), 3.8 (d, 1H), 3.6 (m, 1H), 3.1 (t, 1H), 2.8 (t, 1H), 1.9 (t, 2H), 1.45 (m, 2H).

後処理

  1. customthe precipitate was collected
  2. customThe solid was purified by recrystallisation from ethyl acetate The residue
  3. customobtained
  4. customwas again purified by column chromatography (using 60-120 silica gel and 60% EtOAc in hexane as eluent)

出典と根拠

ORDレコード
ord-8ea231cdd8364b5e86f080b2209e7415
出典データセット
uspto-grants-2012_03
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08129376B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート